| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 10.1% | -30% | $33.8M | -$14.1M | 11.1M | -29.4% | FMR LLC | 30 Sep 2025 |
| Satter Muneer A | 7.2% | $36M | 10.4M | Satter Muneer A | 19 Nov 2025 | |||
| VANGUARD GROUP INC | 5.31% | +8.2% | $17.8M | $1.39M | 5.84M | +8.47% | The Vanguard Group | 30 Sep 2025 |
| Bain Capital Life Sciences Fund, L.P. | 4.9% | $9.97M | 5.25M | BCLS I Investco, LP | 31 Dec 2024 | |||
| Point72 Asset Management, L.P. | 0.1% | $181K | 95.4K | Point72 Asset Management, L.P. | 31 Mar 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 101M | $309M | +$11.2M | $3.05 | 144 |
| 2025 Q2 | 99.4M | $239M | +$760K | $2.40 | 127 |
| 2025 Q1 | 99.5M | $192M | -$14.2M | $1.93 | 146 |
| 2024 Q4 | 112M | $574M | +$7.29M | $5.13 | 151 |
| 2024 Q3 | 110M | $651M | +$12.1M | $5.92 | 141 |
| 2024 Q2 | 107M | $526M | +$50.6M | $4.90 | 139 |
| 2024 Q1 | 94.8M | $679M | +$108M | $7.17 | 125 |
| 2023 Q4 | 80.5M | $366M | +$126M | $4.54 | 98 |
| 2023 Q3 | 53.3M | $126M | -$910K | $2.36 | 91 |
| 2023 Q2 | 53.4M | $188M | -$1.83M | $3.52 | 93 |
| 2023 Q1 | 54M | $208M | +$11.6M | $3.85 | 98 |
| 2022 Q4 | 47M | $243M | +$3.85M | $5.17 | 81 |
| 2022 Q3 | 46.3M | $286M | +$50M | $6.18 | 69 |
| 2022 Q2 | 38.4M | $145M | +$5.36M | $3.77 | 74 |
| 2022 Q1 | 38.6M | $105M | -$23.8M | $2.73 | 96 |
| 2021 Q4 | 38.8M | $446M | +$6.73M | $11.49 | 94 |
| 2021 Q3 | 38.1M | $709M | -$28.8M | $18.61 | 81 |
| 2021 Q2 | 38.9M | $874M | +$29.7M | $22.51 | 73 |
| 2021 Q1 | 37.4M | $1.04B | +$38.8M | $27.84 | 72 |
| 2020 Q4 | 36.2M | $904M | -$17.9M | $25.03 | 70 |
| 2020 Q3 | 34.8M | $1.04B | +$1.04B | $30.23 | 65 |